Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Forns

Showing results (241-250 of 298) with videos related to

Pageof 30
Sort By:
The Lancet. Infectious Diseases|August 19, 2017
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trialXavier Forns, Samuel S Lee, Joaquin Valdes, et al.
Communications Medicine|December 14, 2023
Community-based screening enhances hepatitis B virus linkage to care among West African migrants in SpainCamila A Picchio, Daniel K Nomah, Ariadna Rando-Segura, et al.
Hepatology (Baltimore, Md.)|January 16, 2010
Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humansMontserrat Moreno, Javier F Chaves, Pau Sancho-Bru, et al.
Journal of Gastroenterology and Hepatology|January 21, 2020
Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antiviralsSergio Rodríguez-Tajes, Ángela Domínguez, Jose Antonio Carrión, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 3, 2025
HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T CellsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Journal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.
Advances in Laboratory Medicine|June 26, 2023
Control of occult hepatitis B virus infectionMarta Lalana Garcés, Oihana Ortiz Pastor, Gemma Solé Enrech, et al.
Journal of Hepatology|June 15, 2020
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertensionSabela Lens, Anna Baiges, Edilmar Alvarado-Tapias, et al.
Gastroenterology|July 24, 2017
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated CirrhosisSabela Lens, Edilmar Alvarado-Tapias, Zoe Mariño, et al.
The Journal of Experimental Medicine|July 1, 2020
Longevity and replenishment of human liver-resident memory T cells and mononuclear phagocytesLaura J Pallett, Alice R Burton, Oliver E Amin, et al.
Pageof 30

Showing results (241-250 of 298) with videos related to

Sort By:
Pageof 30
The Lancet. Infectious Diseases|August 19, 2017
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trialXavier Forns, Samuel S Lee, Joaquin Valdes, et al.
Communications Medicine|December 14, 2023
Community-based screening enhances hepatitis B virus linkage to care among West African migrants in SpainCamila A Picchio, Daniel K Nomah, Ariadna Rando-Segura, et al.
Hepatology (Baltimore, Md.)|January 16, 2010
Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humansMontserrat Moreno, Javier F Chaves, Pau Sancho-Bru, et al.
Journal of Gastroenterology and Hepatology|January 21, 2020
Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antiviralsSergio Rodríguez-Tajes, Ángela Domínguez, Jose Antonio Carrión, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 3, 2025
HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T CellsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Journal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.
Advances in Laboratory Medicine|June 26, 2023
Control of occult hepatitis B virus infectionMarta Lalana Garcés, Oihana Ortiz Pastor, Gemma Solé Enrech, et al.
Journal of Hepatology|June 15, 2020
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertensionSabela Lens, Anna Baiges, Edilmar Alvarado-Tapias, et al.
Gastroenterology|July 24, 2017
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated CirrhosisSabela Lens, Edilmar Alvarado-Tapias, Zoe Mariño, et al.
The Journal of Experimental Medicine|July 1, 2020
Longevity and replenishment of human liver-resident memory T cells and mononuclear phagocytesLaura J Pallett, Alice R Burton, Oliver E Amin, et al.
Pageof 30